PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Inhibition of canonical WNT signaling pathway by beta-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29217140 ↗2017Reported benefit

Inhibition of canonical WNT signaling pathway by beta-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12.

MouseChemical/toxinC57BL/6Male

Model: Carbon tetrachloride-induced acute liver injury in mice, with in vitro TGF-beta-activated 3T3 fibroblasts, LX2 cells and primary human hepatic stellate cells

ICG-001 significantly attenuated collagen accumulation and hepatic stellate cell activation in vivo and markedly reduced macrophage infiltration, intrahepatic inflammation and angiogenesis. CXCL12 was suppressed both in vitro and in vivo, and Wnt-regulated CXCL12 secretion from activated stellate c…

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.